Ionis Pharmaceuticals, Inc. · NASDAQ:IONS
Bennett C Frank sold 20,536 Ionis Pharmaceuticals, Inc. shares (Form 4)
Traded Jul 7, 2026 · Filed Jul 9, 2026
On Jul 7, 2026, Bennett C Frank (EVP, Chief Scientific Officer) sold 20,536 Ionis Pharmaceuticals, Inc. shares at an average US$84.95 for US$1.74M under a trading plan, leaving 0 shares. Filed Jul 9, 2026 (Form 4).
- Sold
- 20,536 shares
- Price
- US$84.95 average (US$83.58 to US$85.46)
- Value
- US$1.74M
- Holding after
- 0 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | Common Stock | Sale | 5,536 | US$83.58 | 75,018 | Direct |
| Jul 7, 2026 | Common Stock | Other | 15,000 | 15,000 | Indirect | |
| Jul 7, 2026 | Common Stock | Sale | 15,000 | US$85.46 | 0 | Indirect |
Source
Related
- Ionis Pharmaceuticals, Inc.
- Bennett C Frank
- Ionis Pharmaceuticals, Inc. shareholders
- Form 4 · Bennett C Frank · Sep 2, 2026
- Form 4 · Devers Shannon L. · Oct 19, 2026
- Form 4 · Swayze Eric · Oct 19, 2026
- Form 4 · O'Neil Patrick R. · Sep 2, 2026
- Form 4 · Monia Brett P · Sep 2, 2026
- Form 4 · Birchler Brian · Sep 2, 2026